Javascript must be enabled to continue!
The influence of timing of oocytes retrieval and embryo transfer on the IVF-ET outcomes in patients having bilateral salpingectomy due to bilateral hydrosalpinx
View through CrossRef
ObjectiveThe objective of the study was to investigate whether the sequence of oocyte retrieval and salpingectomy for hydrosalpinx affects pregnancy outcomes of in vitro fertilization and embryo transfer (IVF-ET) patients.Study DesignThere were 1,610 bilateral hydrosalpinx patients who underwent laparoscopy salpingectomy and IVF-ET/intracytoplasmic sperm injection (ICSI) from January 2009 to December 2018. They were divided into two groups: oocyte retrieval first group: 235 accepted oocyte retrieval before salpingectomy; operation first group: 1,375 accepted oocyte retrieval after salpingectomy. The basic information and pregnancy outcomes of the two groups were compared. The pregnancy outcomes and influencing factors were analyzed among patients at different starting times of frozen-thawed embryo transfer (FET) or oocyte retrieval after the salpingectomy.ResultsPatients in the oocyte retrieval first group had higher levels of basal follicle stimulating hormone and lower anti-Mullerian hormone levels (P < 0.05). There were no cases of pelvic infection or oocyte and embryo contamination after oocyte retrieval in the oocyte retrieval first group. In the frozen cycle, the clinical pregnancy and miscarriage rates of the oocyte retrieval first group were lower than those in the operation first group (P < 0.05), while the live birth rate was not significantly different (P > 0.05). The live birth rates of patients ≥35 years old in the operation first group and the oocyte retrieval first group were not significantly different (29.3% vs. 23.3%, P = 0.240). After adjusting for age and antral follicle count (AFC), oocyte retrieval 4–6 and 7–12 months after the operation had higher accumulated pregnancy rates [OR 1.439 (1.045–1.982), P = 0.026; OR 1.509 (1.055–2.158), P = 0.024] and higher accumulated live birth rates [OR 1.419 (1.018–1.977), P = 0.039; OR 1.544 (1.068–2.230), P = 0.021]. No significant difference was observed in the pregnancy outcomes of frozen embryo transfer at different times after salpingectomy (P > 0.05).ConclusionNo contamination of the embryo or infection was observed in patients who underwent oocyte retrieval before the operation. The interval between the operation and frozen embryo transfer did not affect the pregnancy outcomes. After adjusting for age and AFC, patients who underwent oocyte retrieval 4–6 and 7–12 months after the operation had higher accumulated pregnancy rates and live birth rates.
Frontiers Media SA
Title: The influence of timing of oocytes retrieval and embryo transfer on the IVF-ET outcomes in patients having bilateral salpingectomy due to bilateral hydrosalpinx
Description:
ObjectiveThe objective of the study was to investigate whether the sequence of oocyte retrieval and salpingectomy for hydrosalpinx affects pregnancy outcomes of in vitro fertilization and embryo transfer (IVF-ET) patients.
Study DesignThere were 1,610 bilateral hydrosalpinx patients who underwent laparoscopy salpingectomy and IVF-ET/intracytoplasmic sperm injection (ICSI) from January 2009 to December 2018.
They were divided into two groups: oocyte retrieval first group: 235 accepted oocyte retrieval before salpingectomy; operation first group: 1,375 accepted oocyte retrieval after salpingectomy.
The basic information and pregnancy outcomes of the two groups were compared.
The pregnancy outcomes and influencing factors were analyzed among patients at different starting times of frozen-thawed embryo transfer (FET) or oocyte retrieval after the salpingectomy.
ResultsPatients in the oocyte retrieval first group had higher levels of basal follicle stimulating hormone and lower anti-Mullerian hormone levels (P < 0.
05).
There were no cases of pelvic infection or oocyte and embryo contamination after oocyte retrieval in the oocyte retrieval first group.
In the frozen cycle, the clinical pregnancy and miscarriage rates of the oocyte retrieval first group were lower than those in the operation first group (P < 0.
05), while the live birth rate was not significantly different (P > 0.
05).
The live birth rates of patients ≥35 years old in the operation first group and the oocyte retrieval first group were not significantly different (29.
3% vs.
23.
3%, P = 0.
240).
After adjusting for age and antral follicle count (AFC), oocyte retrieval 4–6 and 7–12 months after the operation had higher accumulated pregnancy rates [OR 1.
439 (1.
045–1.
982), P = 0.
026; OR 1.
509 (1.
055–2.
158), P = 0.
024] and higher accumulated live birth rates [OR 1.
419 (1.
018–1.
977), P = 0.
039; OR 1.
544 (1.
068–2.
230), P = 0.
021].
No significant difference was observed in the pregnancy outcomes of frozen embryo transfer at different times after salpingectomy (P > 0.
05).
ConclusionNo contamination of the embryo or infection was observed in patients who underwent oocyte retrieval before the operation.
The interval between the operation and frozen embryo transfer did not affect the pregnancy outcomes.
After adjusting for age and AFC, patients who underwent oocyte retrieval 4–6 and 7–12 months after the operation had higher accumulated pregnancy rates and live birth rates.
Related Results
O-196 The impact of providing couples with their IVF-prognosis on the expectations and anxiety of women and men
O-196 The impact of providing couples with their IVF-prognosis on the expectations and anxiety of women and men
Abstract
Study question
What is the impact of providing couples with their IVF-prognosis on expectations and anxiety in women an...
Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?
Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?
AbstractSTUDY QUESTIONOver a time period of 3 years, which order of expectant management (EM), IUI with ovarian stimulation (IUI-OS) and IVF is the most cost-effective for couples ...
O-089 The impact of sharing personalized IVF-prognoses: a randomized controlled trial
O-089 The impact of sharing personalized IVF-prognoses: a randomized controlled trial
Abstract
Study question
Are women less likely to expect unrealistic live birth rates (i.e. 100% or > 2x their personalize...
O-105 Chromatin accessibility of oocytes contributes to PCOS transgenerational inheritance
O-105 Chromatin accessibility of oocytes contributes to PCOS transgenerational inheritance
Abstract
Study question
What is the underlying mechanism contributing to the transgenerational defects of oocytes and embryos of...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
P-229 Has rampant use of ICSI wiped out Conventional IVF for non male factor infertility, or can Conventional IVF hold its ground
P-229 Has rampant use of ICSI wiped out Conventional IVF for non male factor infertility, or can Conventional IVF hold its ground
Abstract
Study question
Can ICSI completely replace and produce higher implantation rates as compared to conventional IVF for no...
284 FERTILIZING CAPACITY OF BUFFALO (BUBALUS BUBALIS) SPERM CO-CULTURED WITH OVIDUCT EPITHELIAL CELLS
284 FERTILIZING CAPACITY OF BUFFALO (BUBALUS BUBALIS) SPERM CO-CULTURED WITH OVIDUCT EPITHELIAL CELLS
The overall in vitro embryo production efficiency in buffalo is hampered by the poor IVF efficiency. The aim of this work was to evaluate whether the fertilizing ability of buffalo...
P-791 Supplementation of mitochondria from endometrial mesenchymal stem cells (EnMSCs) improves oocyte quality in aged mice
P-791 Supplementation of mitochondria from endometrial mesenchymal stem cells (EnMSCs) improves oocyte quality in aged mice
Abstract
Study question
To improve the quality of aging oocytes by supplementing the mitochondria from endometrial mesenchymal s...

